Putting patients first in medicines regulation? (30 November 2021)

Summary

On 4 July 2021, the Medicines and Healthcare Products Regulatory Agency (MHRA) published its delivery plan for 2021-2023: Putting Patients First: a New Era for our Agency. In this plan, the MHRA promises to make drug regulation in the UK more patient centred, while being “an agile and supportive regulator” to accommodate the interests of the United Kingdom’s life sciences industry. In this BMJ Editorial, Huseyin Naci and colleagues argues that the MHRA’s new delivery plan strikes the wrong note.